Atorvastatin

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

144 Suppliers, 70 USDMF, 42 CEP/COS, 22 JDMF, 30 EU WC, 89 KDMF, 23 NDC API, 69 Listed Suppliers

DEVELOPMENTS

12 Drug(s) in Development

12 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

17 Suppliers

17 Suppliers

DOSSIERs // Finished Dosage Forms

1360 Dossiers, 183 FDA Orange Book, 605 Europe, 107 Canada, 103 Australia, 77 South Africa, 285 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 40MG BASE, TABLET;ORAL - EQ 80MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 22 SPI Pharma, 20 Roquette, 18 BASF, 17 Microlex e.U, 13 Seppic, 12 Corel Pharma Chem, 12 Gangwal Healthcare, 12 Sigachi Industries, 10 Gangwal Chemicals, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Ideal Cures Pvt Ltd, 7 DFE Pharma, 7 Actylis, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Prachin Chemical, 5 DKSH, 5 Ingredion Pharma Solutions, 5 Nanjing Well Pharmaceutical, 4 Vasa Pharmachem, 4 Kima Chemical, 3 The Dow Chemical Company, 3 Pharmatrans-Sanaq, 3 Jai Radhe Sales, 3 Rochem International Inc, 2 Aeon Procare, 2 Kewpie Corporation, 2 Alcedo Pharmachem, 2 Pfanstiehl, 2 Nomisma Healthcare, 2 Seqens, 1 Huzhou Sunflower Pharmaceutical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Pharm-RX Chemical, 1 Shijiazhuang Huaxu Pharmaceutical, 1 NEWEDGE Overseas, 1 ACG Worldwide, 1 Evonik, 1 Chynops Pharma, 1 BioSpectra, 1 Qualicaps, 1 Nanjing Bold Chemical, 1 Minakem, 1 Boai NKY Pharmaceuticals Ltd, 1 Finar

EXCIPIENTS BY APPLICATIONS

83 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 43 Direct Compression, 34 Disintegrants & Superdisintegrants, 31 Controlled & Modified Release, 26 Thickeners and Stabilizers, 23 Granulation, 22 Solubilizers, 22 Lubricants & Glidants, 21 Taste Masking, 19 Chewable & Orodispersible Aids, 17 Parenteral, 16 Co-Processed Excipients, 15 Film Formers & Plasticizers, 15 Topical, 10 Emulsifying Agents, 9 API Stability Enhancers, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

17 US Medicaid Prescriptions, 477 Finished Drug Prices

MARKET PLACE

52 APIs, 21 DOSSIERS // FDF, 1 Intermediates

PATENTS

3 US Patents, 72 Health Canada Patents

ANALYTICAL SOLUTION(s)

5 BioAnalytical Methods, 6 EDQM Standards, 7 USP Standards, 4 JP Standards, 16 Other Ref. Standards

DIGITAL CONTENT

14 Data Compilation & Company Tracker #PharmaFlow, 150 News

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Atorvastatin

Atorvastatin

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

144 Suppliers

70 USDMF

42 CEP/COS

22 JDMF

30 EU WC

89 KDMF

23 NDC API

69 Listed Suppliers

DEVELOPMENTS

12 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

17 Suppliers

DOSSIERs // Finished Dosage Forms

1360 Dossiers

183 FDA Orange Book

605 Europe

107 Canada

103 Australia

77 South Africa

285 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 20MG BASE

TABLET;ORAL - EQ 40MG BASE

TABLET;ORAL - EQ 80MG BASE

TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE

TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE

TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE

TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE

TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE

TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE

TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

39 Kerry

22 SPI Pharma

20 Roquette

18 BASF

17 Microlex e.U

13 Seppic

12 Corel Pharma Chem

12 Gangwal Healthcare

12 Sigachi Industries

10 Gangwal Chemicals

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Ideal Cures Pvt Ltd

7 DFE Pharma

7 Actylis

6 Lonza Capsugel

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Prachin Chemical

5 DKSH

5 Ingredion Pharma Solutions

5 Nanjing Well Pharmaceutical

4 Vasa Pharmachem

4 Kima Chemical

3 The Dow Chemical Company

3 Pharmatrans-Sanaq

3 Jai Radhe Sales

3 Rochem International Inc

2 Aeon Procare

TABLET;ORAL - EQ 10MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 80MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons